Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy

被引：0
|
作者：
Jennifer A McAlpine
Hsin-Tze Lu
Katherine C Wu
Susan K Knowles
James A Thomson
机构：
[1] Polaris Pharmaceuticals,Department of Biology
来源：
BMC Cancer | / 14卷
关键词：
Arginine; Argininosuccinate synthetase; Arginine deiminase; Cisplatin; Hepatocellular carcinoma; Combination therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 19 条
  • [1] Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
    McAlpine, Jennifer A.
    Lu, Hsin-Tze
    Wu, Katherine C.
    Knowles, Susan K.
    Thomson, James A.
    BMC CANCER, 2014, 14
  • [2] Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
    Shih-Chang Shiue
    Miao-Zeng Huang
    Ting-Fen Tsai
    Alice Chien Chang
    Kong Bung Choo
    Chiu-Jung Huang
    Tsung-Sheng Su
    Journal of Biomedical Science, 22
  • [3] Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
    Shiue, Shih-Chang
    Huang, Miao-Zeng
    Tsai, Ting-Fen
    Chang, Alice Chien
    Choo, Kong Bung
    Huang, Chiu-Jung
    Su, Tsung-Sheng
    JOURNAL OF BIOMEDICAL SCIENCE, 2015, 22
  • [4] Down-regulation of P-Glycoprotein Is Associated with Resistance to Cisplatin and VP-16 in Human Lung Cancer Cell Lines
    Wang, Jiarui
    Wang, Huiling
    Zhao, Long
    Fan, Sufang
    Yang, Zhonghai
    Gao, Fei
    Chen, Lixia
    Xia, Gary Guishan
    Molnar, Joseph
    Wang, Qi
    ANTICANCER RESEARCH, 2010, 30 (09) : 3593 - 3598
  • [5] Down-regulation of PTEN expression due to loss of promoter activity in human hepatocellular carcinoma cell lines
    Dong-Zhu Ma
    World Journal of Gastroenterology, 2005, (29) : 4472 - 4477
  • [6] Down-regulation of PTEN expression due to loss of promoter activity in human hepatocellular carcinoma cell lines
    Ma, Dong-Zhu
    Xu, Zhen
    Liang, Yu-Long
    Su, Jian-Ming
    Li, Zeng-Xia
    Zhang, Wen
    Wang, Li-Ying
    Zha, Xi-Liang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (29) : 4472 - 4477
  • [7] Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1
    Huang, Xiao-Ping
    Li, Xuan
    Situ, Min-Yi
    Huang, Li-Yun
    Wang, Jun-Ye
    He, Tian-Cheng
    Yan, Qi-Hang
    Xie, Xiu-Ying
    Zhang, Yu-Jing
    Gao, Yuan-Hong
    Li, Yu-Hong
    Rong, Tie-Hua
    Wang, Ming-Rong
    Cai, Qing-Qing
    Fu, Jian-Hua
    CANCER LETTERS, 2018, 414 : 294 - 300
  • [8] Down-Regulation of Vitamin D Receptor in Mammospheres: Implications for Vitamin D Resistance in Breast Cancer and Potential for Combination Therapy
    Pervin, Shehla
    Hewison, Martin
    Braga, Melissa
    Lac Tran
    Chun, Rene
    Karam, Amer
    Chaudhuri, Gautam
    Norris, Keith
    Singh, Rajan
    PLOS ONE, 2013, 8 (01):
  • [9] Phase 1 dose-expansion study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1 (ASS1)-deficient non-squamous non-small cell lung cancer.
    Wimalasingham, Akhila Ganeshi
    Phillips, Melissa Mary
    Lim, Louise
    Rashid, Sukaina
    Hall, Peter Edward
    Khadeir, Ramsay
    Steele, Jeremy P. C.
    Conibear, John
    Feng, Xiaoxing
    Ellis, Stephen
    Chan, Pui Ying
    Thomson, Jim
    Johnston, Amanda L.
    Bomalaski, John S.
    Pacey, Simon
    Sheaff, Michael
    Szlosarek, Peter Wojciech
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells
    Biswas, SK
    Huang, J
    Persaud, S
    Basu, A
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (03) : 327 - 334
12